Exponent (EXPO) Earnings Date & Reports

Key Takeaways

• Total revenues climbed 18% year over year to $173.7 million, while net revenues (revenues before reimbursements) rose 12% to $153.1 million.
• Diluted earnings per share (EPS) increased 16% to $0.64, topping consensus estimates of roughly $0.60 to $0.63.
• Net income grew 10% to $30.9 million, and EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 16% to $45.0 million.
• Consultant utilization improved to 76.7% from 74.1% a year earlier, and the realized billing rate increased about 4%.
• Management raised full-year guidance, now expecting net revenues to grow 10% to 11% with an EBITDA margin of 28.0% to 28.3%.
• The company declared a regular quarterly dividend of $0.31 per share, payable on December 18, 2026.
• For more context on this stock, explore its Major News, Today's Price Move, Price Targets, and Forecast pages.
• Discover AI-driven trading ideas and market opportunities with Trending AI Robots.

Earnings Context and Why It Matters

Exponent, Inc. (EXPO) is a science and engineering consulting firm whose work spans product failure analysis, litigation support, and user research. Its results serve as a read on how much businesses are willing to spend on high-stakes technical expertise, even when economic conditions are uncertain. Heading into the third quarter, investors were watching whether the company could sustain momentum after a standout second quarter. The report delivered double-digit growth across revenues, earnings, and profitability, reinforcing that demand for Exponent's specialized services remains resilient. With artificial intelligence becoming a growing share of the business and management lifting its outlook, the quarter offers investors a clearer signal on both near-term execution and the durability of the firm's long-term growth drivers.

Reported Results

For the third quarter of fiscal year 2026 ended October 2, 2026, Exponent reported total revenues of $173.7 million, an 18% increase from $147.1 million in the prior-year period. Revenues before reimbursements, which management views as a more meaningful measure of underlying performance, grew 12% to $153.1 million from $137.1 million. The gap reflects higher reimbursable expenses that flow through total revenues but do not drive profitability.

Net income increased 10% to $30.9 million, while diluted EPS rose 16% to $0.64 from $0.55 a year earlier. The result beat consensus expectations, which ranged from roughly $0.60 to $0.63 per share. EBITDA climbed 16% to $45.0 million, producing a margin of 29.4% of net revenues, up from 28.3% in the same quarter last year.

Operating metrics were also strong. Billable hours rose 8% to approximately 405,000, consultant utilization improved to 76.7%, and the average technical full-time equivalent (FTE) headcount increased 4% to 1,016. The engineering and other scientific segment, which represented 85% of net revenues, grew 13%, while the environmental and health segment, at 15% of net revenues, grew 3%.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Exponent, it offers a streamlined way to surface relevant opportunities and monitor shifting market conditions.

Market Reaction and Investor Sentiment

Exponent entered the quarter with elevated expectations following a strong second quarter, and the third-quarter report again exceeded consensus estimates on both the top and bottom lines. The company has now surpassed consensus EPS estimates for four consecutive quarters, a track record that has supported investor confidence in the stock. Management's decision to raise full-year revenue and margin guidance provided an additional positive signal, indicating that the momentum is not merely the result of favorable project timing.

Investor attention also focused on the company's commentary around artificial intelligence, which management estimated is a direct element of roughly 15% to 20% of the business this year. This growing exposure, combined with improving utilization and a higher realized billing rate, helped frame the results as evidence of both demand strength and disciplined execution.

Forward Outlook and Key Factors to Monitor

Exponent raised its guidance for the remainder of the fiscal year. For the fourth quarter, the company expects revenues before reimbursements to grow 8% to 10% year over year, with EBITDA projected at 26.3% to 26.8% of net revenues. For full fiscal year 2026, management now anticipates net revenue growth of 10% to 11% and an EBITDA margin of 28.0% to 28.3%.

Several factors will be important to watch next. First, utilization and headcount trends will indicate whether Exponent can continue scaling its operating model while managing compensation costs, a key concern given ongoing competition for engineering talent. Second, the pace of user research and artificial intelligence-related engagements will show whether the company's fastest-growing demand drivers remain intact.

Finally, investors should monitor capital allocation. Exponent repurchased $146.1 million of stock through the first three quarters and continues to pay a quarterly dividend, while holding $114.7 million in cash. How management balances shareholder returns against investments in infrastructure and talent will shape profitability and long-term growth. These elements, rather than any single quarterly figure, will likely define the stock's trajectory in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations